CollPlant Biotechnologies (CLGN) Current Deferred Revenue (2018 - 2021)
CollPlant Biotechnologies (CLGN) reported Current Deferred Revenue of $32000.0 for Q4 2021, down 84.54% on a YoY basis from $207000.0 in Q4 2020, and down 80.49% quarter-over-quarter from $164000.0 in Q1 2021.
CollPlant Biotechnologies (CLGN) Current Deferred Revenue (2018 - 2021) Analysis & Trends
CollPlant Biotechnologies has reported Current Deferred Revenue for 4 years, with the latest figure at $32000.0 in Q4 2021.
- For the quarter ending Q4 2021, Current Deferred Revenue fell 84.54% year-over-year to $32000.0; the trailing twelve-month figure through Dec 2021 stood at $32000.0 (down 84.54% YoY), and the FY2021 full-year result was $32000.0, down 84.54% from the prior year.
- Current Deferred Revenue for Q4 2021 stood at $32000.0, down from $164000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.3 million in Q1 2019, with the low at $32000.0 in Q4 2021.
- Historically, Current Deferred Revenue has averaged $658363.6 across 4 years, with a median of $687000.0 in 2020.
- Annual changes were most pronounced in 2019 — Current Deferred Revenue retreated 3.88% — and 2021, when it plunged 84.54%.
- CollPlant Biotechnologies' Current Deferred Revenue stood at $980000.0 in 2018, then fell by 3.88% to $942000.0 in 2019, then slumped by 78.03% to $207000.0 in 2020, then sank by 84.54% to $32000.0 in 2021.
- The last three Current Deferred Revenue figures came in at $32000.0 (Q4 2021), $164000.0 (Q1 2021), and $207000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 32,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Dec 31, 2020 | 207,000.00 |
| Sep 30, 2020 | 317,000.00 |
| Jun 30, 2020 | 297,000.00 |
| Mar 31, 2020 | 687,000.00 |
| Dec 31, 2019 | 942,000.00 |
| Sep 30, 2019 | 1.11 Mn |
| Jun 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 980,000.00 |